Newsroom

SAN FRANCISCO--(BUSINESS WIRE)--Udemy (Nasdaq: UDMY), a global AI-powered skills acceleration platform, today announced the launch of an end-to-end certification journey with a significant expansion of its Amazon Web Services (AWS) certification resources. Learners can now purchase AWS exam vouchers for 12 certifications on Udemy’s global marketplace, access top-rated courses and practice exams from certified experts, and get automated guidance to stay on track with exam scheduling. This strate...

LONDON--(BUSINESS WIRE)--  Funds Date TIDM ISIN Code Shares in Issue Currency Net Asset Value NAV/per Share First Trust NASDAQ Clean Edge Green Energy UCITS ETF 23.02.2026 QCLN.LN IE00BDBRT036 700,002.00 USD 13,549,782.39 19.357  ...

MINNEAPOLIS--(BUSINESS WIRE)--DiaMedica Therapeutics Inc. (Nasdaq: DMAC), a clinical-stage biopharmaceutical company focused on developing novel treatments for preeclampsia, fetal growth restriction and acute ischemic stroke, today announced that company management will participate in three upcoming investment bank conferences. Details TD Cowen 46th Annual Healthcare Conference Boston, Massachusetts  Fireside chat with Rick Pauls, CEO, and Julie Krop, M.D., Chief Medical Officer, on Monday, Mar...

新泽西州泽西市--(BUSINESS WIRE)--(美国商业资讯)-- Organon (NYSE: OGN)是一家全球性医疗保健公司，其使命是提供有影响力的药物和解决方案，以改善人们的日常健康。公司今日宣布已与Sebela Pharmaceuticals达成协议，获得其无激素含铜宫内节育器(IUD)避孕药具MIUDELLA的全球独家授权。本次交易的生效须经《哈特-斯科特-罗迪诺反托拉斯改进法》审核，并获得美国食品药品管理局(FDA)对MIUDELLA替代供应链主体的批准，以及满足若干其他条件。 MIUDELLA是近40年来美国获批的首款无激素含铜IUD，与Organon的商业化能力形成互补，将进一步推动Organon打造满足女性多样化生殖健康需求的产品组合的承诺。MIUDELLA于2025年2月24日获FDA批准，用于育龄女性避孕，有效期最长可达三年，目前尚未上市销售。MIUDELLA为寻求长效、可逆、无激素避孕方式的女性提供了额外选择。MIUDELLA采用独特的柔性支架和全预装置入器，置入管直径仅3.7毫米，细小且呈锥形。1 根据协议条款，Organon将在交易完成时支付2750...

PLANO, Texas--(BUSINESS WIRE)--Tyler Technologies will participate in four investor conferences in March 2026....

WALTHAM, Mass.--(BUSINESS WIRE)--Evolv Technologies Holdings, Inc. (NASDAQ: EVLV), a leading security technology company pioneering AI-based solutions designed to create safer experiences, today announced that Evolv Express® has been selected for use stadium-wide at Inter Miami CF's new home located at Miami Freedom Park. Evolv Express Gen2 systems will be installed at the new 25,000-seat Florida stadium, which is slated to open on April 4, 2026. Evolv Express was designed to allow people to mo...

SAN DIEGO--(BUSINESS WIRE)--Virewirx has been awarded a Phase II $1.9 million Small Business Innovation Research (SBIR) OUSW (R&E) FutureG contract from the Office of the Under Secretary of War (OUSW) to develop an advanced 5G system designed to perform reliably in challenging Radio Frequency (RF) environments. This breakthrough technology will enable mission-critical communications in previously impossible environments, ensuring warfighters maintain connectivity for coordination, safety, a...

BELLEVUE, Wash.--(BUSINESS WIRE)--Terreno Realty Corporation Announces Leases in Redondo Beach, CA...

NATICK, Mass.--(BUSINESS WIRE)--Allurion Technologies, Inc. (NYSE: ALUR) (the “Company” or “Allurion”), a pioneer in metabolically healthy weight loss, today announced the entry into a definitive agreement for the immediate exercise of certain outstanding warrants to purchase up to an aggregate of 2,659,565 shares of common stock, issued by the Company on January 27, 2025 (the “January 2025 Warrants”), February 20, 2025 (the “February 2025 Warrants”) and November 12, 2025 (the “November 2025 Wa...

TEMPLE, Texas--(BUSINESS WIRE)--McLane Company unveils new McLane Fresh products at Convenience Retailing University 2026....